| |
How Do Patents And Economic Policies Affect Access To Essential Medicines In Developing Countries?
Amir Attaran
This paper studies the relationship between patents and access to essential medicines. It finds that in sixty-five low- and middle-income countries, where four billion people live, patenting is rare for 319 products on the World Health Organizations Model List of Essential Medicines. Only seventeen essential medicines are patentable, although usually not actually patented, so that overall patent incidence is low (1.4 percent) and concentrated in larger markets. This and other results shed light on the policy dialogue among public health activists, the pharmaceutical industry, and governments that is often based on mistaken premises about how patents affect corporate revenues or the health of the worlds poorest. Pragmatism and greater flexibility are urged, so that policy may better concentrate on the greater causes of epidemic mortality, which now pose unprecedented threats to global peace and security.

What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Selgelid
A Full-Pull Program for the Provision of Pharmaceuticals: Practical Issues
Public Health Ethics,
May 27, 2008;
(2008)
phn022v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sridhar
Improving Access to Essential Medicines: How Health Concerns Can Be Prioritised in the Global Governance System
Public Health Ethics,
May 3, 2008;
(2008)
phn012v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Ridley, H. G. Grabowski, and J. L. Moe
Developing drugs for developing countries.
Health Aff.,
March 1, 2006;
25(2):
313 - 324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Mulligan
Medicaid Embraces Managed Care As Private Insurers Turn Away
Psychiatr News,
May 21, 2004;
39(10):
2 - 12.
[Full Text]
|
 |
|
eLetters:
Read all eLetters
- Patents And Access: Another Look
- Connie Liu, et al.
- Health Affairs, 11 May 2004
[Full text]
|